Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

ASLAN Pharmaceuticals acquires rights to atopic dermatitis asset

pharmaceutical-technologyJune 05, 2019

Tag: ASLAN Pharmaceuticals , Acquires , Dermatitis

PharmaSources Customer Service